Validation of a New Method to Measure Cardiac Output: Comparison With Thermodilution

Sponsor
Università Politecnica delle Marche (Other)
Overall Status
Completed
CT.gov ID
NCT01806467
Collaborator
(none)
36
1
9
4

Study Details

Study Description

Brief Summary

Many mini-invasive devices to monitor cardiac output (CO) have been introduced and among them the Pressure Recording Analytical Method (PRAM). The aim of this study is to assess the agreement of PRAM with the intermittent transpulmonary thermodilution (ThD) and continuous pulmonary ThD in measuring CO in hemodynamically unstable patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Hemodynamic monitoring is important in critically ill patients. It is often used to assess a cardiovascular derangements, to help diagnosing the causes and to monitor the response to therapy.

    Pulmonary thermodilution (ThD) is still considered the gold standard reference method for cardiac output (CO) measurement [1]. Its invasiveness, however, often limits or delays its application [2, 3]. In the last decades new less invasive hemodynamic monitoring systems have been developed. The majority of such new devices allows for continuous monitoring of CO and other hemodynamic variables [4].

    Among the various less invasive techniques, the PiCCO (Pulse-induced Contour Cardiac Output) relies on the concept of the "pulse contour methodology" for providing beat-to-beat CO assessment. This method needs transpulmonary ThD calibration. This is a well validated dilution technique [5]. Another minimally invasive system is the Pressure Recording Analytical Method (PRAM). Unlike other systems with pulse contour analysis, the PRAM does not need external or internal calibration factors since it analyzes the pressure waveform at a frequency of 1000 Hz and computes the patient's cardiovascular system impedance using a mathematical algorithm based on the physical theory of perturbations. It only requires a connection to a femoral or radial artery catheter for the acquisition and analysis of the arterial pressure traces [6]. This new method has been validated under different experimental and clinical settings [6-9]. Limited data are available under conditions of hemodynamic instability [10-12]. So far, its accuracy and reliability in assessing CO in hemodynamically unstable patients needs yet to be clarified.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    36 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Continuous Thermodilution, Transpulmonary Thermodilution and Pressure Recording Analytical Method for Cardiac Output Measurement During Hemodynamic Instability: a Prospective Clinical Study
    Study Start Date :
    Aug 1, 2011
    Actual Primary Completion Date :
    Apr 1, 2012
    Actual Study Completion Date :
    May 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    critically ill patients

    patients admitted to the medical-surgical ICU

    post-cardiac surgical patients

    patients admitted to the post-cardiac surgical ICU

    Outcome Measures

    Primary Outcome Measures

    1. Blant-Altman test and coefficient of error of Cardiac Output measured with PRAM towards that measured with thermodilution [Study Period: 9 months]

      Agreement between Cardiac Output measured with PRAM and cardiac output measured with thermodilution (both pulmonary and transpulmonary thermodilution) was determined by the Bland-Altman method. The precision of the measurements was given by the limits of agreement (LoA) (±1.96SD) of the mean difference of the methods compared. Upper and lower LoA were calculated as the bias ± 1.96SD. The percentage error was calculated as the LoA of the bias divided by the mean CO from two methods compared. Thirty per cent was considered an a priori criterion of interchangeability.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    Hemodynamic instability in:
    • septic shock

    • pneumonia

    • polytrauma

    • chronic obstructive pulmonary disease

    • heart failure

    • post operative cardiosurgical patients

    Exclusion Criteria:
    • Atrial fibrillation

    • Pacemaker or implantable cardiac defibrillator

    • Aortic or mitral valve disease

    • Intra-aortic balloon pump

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 AOU Ospedali Riuniti Ancona Ancona Italy 60126

    Sponsors and Collaborators

    • Università Politecnica delle Marche

    Investigators

    • Principal Investigator: Abele Donati, MD, UPollitecnicaDM

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Abele Donati, MD, Professor, Università Politecnica delle Marche
    ClinicalTrials.gov Identifier:
    NCT01806467
    Other Study ID Numbers:
    • 210107
    First Posted:
    Mar 7, 2013
    Last Update Posted:
    Mar 7, 2013
    Last Verified:
    Mar 1, 2013

    Study Results

    No Results Posted as of Mar 7, 2013